MARKET

ZLAB

ZLAB

Zai Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

155.58
+4.12
+2.72%
Pre Market: 155.58 0 0.00% 07:29 05/07 EDT
OPEN
152.74
PREV CLOSE
151.46
HIGH
155.98
LOW
151.31
VOLUME
8
TURNOVER
--
52 WEEK HIGH
193.54
52 WEEK LOW
62.89
MARKET CAP
14.73B
P/E (TTM)
-44.9238
1D
5D
1M
3M
1Y
5Y
Matthews International Capital Management Llc Buys Baidu Inc, Trip. ...
GuruFocus News · 1d ago
Entasis Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
– ATTACK Phase 3 topline data readout remains on track for second half of 2021 – – Strengthened balance sheet with $20M financing – WALTHAM, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biophar...
GlobeNewswire · 1d ago
Zai Lab to Announce First Quarter 2021 Financial Results on May 10, 2021
SHANGHAI and SAN FRANCISCO, April 26, Apr 26, 2021 (GLOBE NEWSWIRE via COMTEX) -- SHANGHAI and SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Zai Lab...
GlobeNewswire · 04/26 11:30
Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option
GlobeNewswire · 04/23 15:49
Analysts Expect Breakeven For Zai Lab Limited (NASDAQ:ZLAB) Before Long
With the business potentially at an important milestone, we thought we'd take a closer look at Zai Lab Limited's...
Simply Wall St. · 04/21 15:49
Zai Lab (ZLAB) President & COO Tao Fu Sold $1.6 million of Shares
GuruFocus News · 04/21 05:52
Zai Lab to Raise $750 Million in Public Offering of ADSs, Ordinary Shares
MT Newswires · 04/21 04:56
Zai lab secures $750M capital raise
Zai Lab (ZLAB) has priced its public offering of ~4.8M ADSs, each representing one ordinary share of the Company, at $150.00/ADS, and 224K ordinary shares, at HK$1164.20/ordinary share. Expected gross
Seekingalpha · 04/21 04:20
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ZLAB. Analyze the recent business situations of Zai Lab through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ZLAB stock price target is 192.11 with a high estimate of 250.00 and a low estimate of 100.58.
EPS
Institutional Holdings
Institutions: 221
Institutional Holdings: 56.48M
% Owned: 59.65%
Shares Outstanding: 94.68M
TypeInstitutionsShares
Increased
88
7.18M
New
34
906.71K
Decreased
42
3.84M
Sold Out
20
330.45K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.01%
Pharmaceuticals & Medical Research
-0.30%
Key Executives
Chairman/Chief Executive Officer/Co-Founder/Director
Du Ying
President/Chief Operating Officer/Director
Fu Tao
Chief Financial Officer
Billy Cho
Corporate Executive
Alan Sandler
Other
F. Ty Edmondson
Independent Director
John Diekman
Independent Director
Chen Kai-Xian
Independent Director
Nisa Leung
Independent Director
William Lis
Independent Director
Leon Moulder
Independent Director
Peter Wirth
No Data
About ZLAB
Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Webull offers kinds of Zai Lab Ltd - ADR stock information, including NASDAQ:ZLAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLAB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZLAB stock methods without spending real money on the virtual paper trading platform.